Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
NeoGenomics, Inc., frequently referred to as Neogenomics, is a leading global cancer testing and information services company headquartered in Fort Myers, Florida, USA, with significant operational presence worldwide. Established in 2002, the company has swiftly become a pivotal force in the rapidly advancing precision oncology field.
Neogenomics specialises in delivering comprehensive oncology testing services, encompassing advanced genomic profiling, molecular diagnostics, and pathology. Their unique offerings support both clinical patient care and pharmaceutical research, crucially aiding in the development of novel cancer therapies and personalised treatment strategies.
As a distinguished leader in the biotechnology and healthcare services sector, Neogenomics provides essential insights for oncologists and pharmaceutical partners. They are dedicated to enhancing cancer care globally through innovative technology and unparalleled expertise, striving for more effective patient outcomes.
25
DitchCarbon score
-11 vs industry average
Neogenomics’s score of 25 is lower than 36% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Neogenomics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Business Services is among the least carbon-intensive industries
Industry performance
0.146
20182025
The Business Services industry has reduced its overall emissions by 25% since 2018
Emissions trajectory 2020 – 2026
2020202120222023202420252026
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Neogenomics's reported carbon emissions
As of 2023, US-based Neogenomics, operating within the "Other business services (74)" industry, reported total Scope 1 and Scope 2 emissions of approximately 4,717,000 kg CO2e. This includes about 536,000 kg CO2e from Scope 1 emissions and roughly 4,181,000 kg CO2e from Scope 2 emissions. Neogenomics has disclosed its Scope 1 and 2 emissions but has not yet reported Scope 3 data for categories such as purchased goods and services, business travel, or employee commute. The company has no publicly available specific reduction targets or climate pledges at this time.
Assessing Neogenomics as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Neogenomics and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Neogenomics’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Neogenomics yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Neogenomics9 months ago
25
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more